InnoCare Pharma Ltd.SSE: 688428

Announcement on Voluntary Disclosure of Phase II Clinical Trial Result of ICP-488

· Issued by InnoCare Pharma Ltd. via Shanghai Stock Exchange

Filed with SSE ·

Announcement on Voluntary Disclosure of Phase II Clinical Trial Result of ICP-488

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

InnoCare Pharma Ltd. on 6ix

Earlier from InnoCare Pharma

Later from InnoCare Pharma

All InnoCare Pharma news releases